NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Texas Southwestern Medical Center
University of Kansas Medical Center
Dana-Farber Cancer Institute
Mayo Clinic
Providence Health & Services
Memorial Sloan Kettering Cancer Center
Oslo University Hospital
The Netherlands Cancer Institute
OHSU Knight Cancer Institute
Centre Leon Berard
Fondazione per la Medicina Personalizzata
Jules Bordet Institute
The Netherlands Cancer Institute
The Netherlands Cancer Institute
Seoul National University Hospital
Istituto Oncologico Veneto IRCCS
Northwestern University